Meyka Pro banner
Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc. (RPID) Stock Overview

Explore Rapid Micro Biosystems, Inc.’s financial performance, market position, analyst ratings, and future outlook.

RPIDNASDAQ
HealthcareMedical - Devices
$2.13
$0.02(0.95%)
U.S. Market opens in 45h 46m

Rapid Micro Biosystems, Inc. (RPID)

Meyka AI Score

Z

Key Financials

Market Cap96.5M
P/E Ratio-1.90
EPS (TTM)$-1.12
ROE-1.32%
Fundamental Analysis

AI Price Forecasts

1 Month$0.49
3 Months$0.00
1 Year Target$2.46

RPID Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Rapid Micro Biosystems, Inc. (NASDAQ: RPID) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Rapid Micro Biosystems, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RPID on the NASDAQ shows an RSI of 61.47, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $2.46 for the NASDAQ listing.

Key metrics behind Rapid Micro Biosystems, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.90 and a market capitalization of 96.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RPID on the NASDAQ.

Price Performance (NASDAQ: RPID)

1-Day Change
0.95%
5-Day Change
6.50%
1-Month Change
23.12%
3-Month Change
-11.25%
6-Month Change
-51.92%
Year-to-Date (YTD) Change
-26.55%
1-Year Change
-36.04%
3-Year Change
117.06%
5-Year Change
-90.96%
All-Time (Max) Change
-90.05%

Contact Information

978 349 3200
25 Hartwell Avenue, Lexington, MA, 02421

Company Facts

1,710 Employees
IPO DateJul 15, 2021
CountryUS
Actively Trading

Frequently Asked Questions